Alexios Matikas

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Alexios Matikas
Mar 4, 2025, 11:14 | Blog
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research…
Feb 21, 2025, 10:00 | Blog
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared a paper he and his…
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Jul 21, 2024, 21:49 | Blog
Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…
Jul 20, 2024, 17:44 | Insight
Piotr Wysocki: Who should not get dose-dense adjuvant chemotherapy in breast cancer?
Piotr Wysocki recently posted on LinkedIn: "For many years, dose-dense adjuvant chemotherapy has been considered the…
Jul 20, 2024, 10:37 | Blog
Personalized Dose-Dense Adjuvant Chemotherapy for High-Risk Early breast cancer
Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…
Jul 19, 2024, 13:20 | Blog
Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…
All: 7 Posts: 1 - 100
Special Coverage